Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,800,429
-
Share change
-
+21,997
-
Total reported value
-
$45,253,510
-
Price per share
-
$25.17
-
Number of holders
-
73
-
Value change
-
+$525,110
-
Number of buys
-
30
-
Number of sells
-
29
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2022
As of 31 Dec 2022,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,800,429 shares.
The largest 10 holders included
MORGAN STANLEY, Wealthcare Advisory Partners LLC, BANK OF AMERICA CORP /DE/, Wharton Business Group, LLC, UBS Group AG, JANE STREET GROUP, LLC, COMMONWEALTH EQUITY SERVICES, LLC, LPL Financial LLC, Royal Bank of Canada, and RiverFront Investment Group, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.